Current status of stem cell mobilization: Review

British Journal of Haematology

Volumn 150, Issue 6, 2010, Pages 647-662

  Gertz, Morie A ^a  

^a MAYO CLINIC   (United States)

Author keywords

growth factors; mobilization; multiple myeloma; non Hodgkin lymphoma; stem cell transplantation

Indexed keywords

ANCESTIM; ANTINEOPLASTIC AGENT; CARBOPLATIN; CD34 ANTIGEN; CEFEPIME; CIPROFLOXACIN; CISPLATIN; CLARITHROMYCIN; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; EPIRUBICIN; ETOPOSIDE; FLUDARABINE; IDARUBICIN; IFOSFAMIDE; MELPHALAN; METHYLPREDNISOLONE; PLERIXAFOR; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; RECOMBINANT STEM CELL FACTOR; UNCLASSIFIED DRUG; VANCOMYCIN;

ACUTE FEBRILE NEUTROPHILIC DERMATOSIS; ACUTE GRANULOCYTIC LEUKEMIA; BONE PAIN; CANCER COMBINATION CHEMOTHERAPY; CLINICAL TRIAL; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG MEGADOSE; FEBRILE NEUTROPENIA; HEMOPTYSIS; HUMAN; LEUKAPHERESIS; LEUKEMIA; LOW DRUG DOSE; LUNG HEMORRHAGE; LYMPHOMA; MYELOMA; NEPHROTOXICITY; NEUROTOXICITY; NEUTROPENIA; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; RESPIRATORY DISTRESS; REVIEW; SINGLE DRUG DOSE; SPLEEN RUPTURE; STEM CELL MOBILIZATION; STEM CELL TRANSPLANTATION; THROMBOCYTOPENIA;

ANTIGENS, CD34; ANTINEOPLASTIC AGENTS; FILGRASTIM; GROWTH SUBSTANCES; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LYMPHOMA, NON-HODGKIN; MULTIPLE MYELOMA; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION;

EID: 77956330290     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2010.08313.x     Document Type: Review

References (144)

1. Ahn, J.S., Park, S., Im, S.-A., Yoon, S.-S., Lee, J.-S., Kim, B.K., Bang, S.-M., Cho, E.K., Lee, J.H., Jung, C.W., Kim, H.C., Seong, C.M., Lee, M.H., Kim, C.S., Lee, K.S., Lee, J.A. Ahn, M.-J. (2005) High-dose versus low-dose cyclophosphamide in combination with G-CSF for peripheral blood progenitor cell mobilization. Korean Journal of Internal Medicine, 20, 224 231.
2. Ataergin, S., Arpaci, F., Turan, M., Solchaga, L., Cetin, T., Ozturk, M., Ozet, A., Komurcu, S. Ozturk, B. (2008) Reduced dose of lenograstim is as efficacious as standard dose of filgrastim for peripheral blood stem cell mobilization and transplantation: a randomized study in patients undergoing autologous peripheral stem cell transplantation. American Journal of Hematology, 83, 644 648.
3. Atta, E.H., de Azevedo, A.M., Maiolino, A., Coelho, C.J., Sarcinelli, S.M., de Alvarenga Maximo, C. Marra, V.L. (2009) High CD8+ lymphocyte dose in the autograft predicts early absolute lymphocyte count recovery after peripheral hematopoietic stem cell transplantation. American Journal of Hematology, 84, 21 28.
4. Avery, R.K., Pohlman, B.L., Mossad, S.B., Goormastic, M., Longworth, D.L., Kalaycio, M.E., Sobecks, R.M., Andresen, S.W., Kuczkowski, E., Bernhard, L., Ostendorf, H., Wise, K. Bolwell, B.J. (2002) The efficacy of prophylactic outpatient antibiotics for the prevention of neutropenic fever associated with high-dose etoposide (VP-16) for stem cell mobilization. Bone Marrow Transplantation, 30, 311 314.
5. Bishton, M.J., Lush, R.J., Byrne, J.L., Russell, N.H., Shaw, B.E. Haynes, A.P. (2007) Ifosphamide, etoposide and epirubicin is an effective combined salvage and peripheral blood stem cell mobilisation regimen for transplant-eligible patients with non-Hodgkin lymphoma and Hodgkin disease. British Journal of Haematology, 136, 752 761.
6. Boccadoro, M., Palumbo, A., Bringhen, S., Merletti, F., Ciccone, G., Richiardi, L., Rus, C., Bertola, A., Giaccone, L., Omede, P. Musto, P. (2002) Oral melphalan at diagnosis hampers adequate collection of peripheral blood progenitor cells in multiple myeloma. Haematologica, 87, 846 850.
7. Boeve, S., Strupeck, J., Creech, S. Stiff, P.J. (2004) Analysis of remobilization success in patients undergoing autologous stem cell transplants who fail an initial mobilization: risk factors, cytokine use and cost. Bone Marrow Transplantation, 33, 997 1003.
8. Breitkreutz, I., Lokhorst, H.M., Raab, M.S., Holt, B., Cremer, F.W., Herrmann, D., Glasmacher, A., Schmidt-Wolf, I.G., Blau, I.W., Martin, H., Salwender, H., Haenel, A., Sonneveld, P. Goldschmidt, H. (2007) Thalidomide in newly diagnosed multiple myeloma: influence of thalidomide treatment on peripheral blood stem cell collection yield. Leukemia, 21, 1294 1299.
9. Canales, M.A., Fernandez-Jimenez, M.C., Martin, A., Arrieta, R., Caballero, M.D., Diez, J., Quevedo, E., Garcia-Bustos, J., San Miguel, J.F. Hernandez-Navarro, F. (2001) Identification of factors associated with poor peripheral blood progenitor cell mobilization in Hodgkin's disease. Haematologica, 86, 494 498.
10. Carlo-Stella, C., Di Nicola, M., Milani, R., Guidetti, A., Magni, M., Milanesi, M., Longoni, P., Matteucci, P., Formelli, F., Ravagnani, F., Corradini, P. Gianni, A.M. (2004) Use of recombinant human growth hormone (rhGH) plus recombinant human granulocyte colony-stimulating factor (rhG-CSF) for the mobilization and collection of CD34+ cells in poor mobilizers. Blood, 103, 3287 3295.
11. Carrion, R., Serrano, D., Gomez-Pineda, A. Diez-Martin, J.L. (2003) A randomised study of 10 microg/kg/day (single dose) vs 2 × 5 microg/kg/day (split dose) G-CSF as stem cell mobilisation regimen in high-risk breast cancer patients. Bone Marrow Transplantation, 32, 563 567.
12. Cassens, U., Momkvist, P.H., Zuehlsdorf, M., Mohr, M., Kienast, J., Berdel, W.E. Sibrowski, W. (2001) Kinetics of standardized large volume leukapheresis (LVL) in patients do not show a recruitment phenomenon of peripheral blood progenitor cells (PBPC). Bone Marrow Transplantation, 28, 13 20.
13. Chiang, K.-Y., Haight, A., Horan, J., Olson, E., Gartner, A., Hartman, D., Youssef, S. Worthington-White, D. (2007) Clinical outcomes and graft characteristics in pediatric matched sibling donor transplants using granulocyte colony-stimulating factor-primed bone marrow and steady-state bone marrow. Pediatric Transplantation, 11, 279 285.
14. Cooling, L., Hoffmann, S., Herrst, M., Muck, C., Armelagos, H. Davenport, R. (2010) A prospective randomized trial of two popular mononuclear cell collection sets for autologous peripheral blood stem cell collection in multiple myeloma. Transfusion, 50, 100 119.
15. Copelan, E., Pohlman, B., Rybicki, L., Kalaycio, M., Sobecks, R., Andresen, S., Dean, R., Koo, A., Chan, J., Sweetenham, J. Bolwell, B. (2009) A randomized trial of etoposide and G-CSF with or without rituximab for PBSC mobilization in B-cell non-Hodgkin's lymphoma. Bone Marrow Transplantation, 43, 101 105.
16. Damon, L., Damon, L.E., Gaensler, K., Kaplan, L., Martin, 3rd., T., Rubenstein, J. Linker, C. (2008) Impact of intensive PBSC mobilization therapy on outcomes following auto-SCT for non-Hodgkin's lymphoma. Bone Marrow Transplantation, 42, 649 657.
17. Dawson, M.A., Schwarer, A.P., Muirhead, J.L., Bailey, M.J., Bollard, G.M. Spencer, A. (2005) Successful mobilization of peripheral blood stem cells using recombinant human stem cell factor in heavily pretreated patients who have failed a previous attempt with a granulocyte colony-stimulating factor-based regimen. Bone Marrow Transplantation, 36, 389 396.
18. De Clercq, E. (2009) The AMD3100 story: the path to the discovery of a stem cell mobilizer (Mozobil). Biochemical Pharmacology, 77, 1655 1664.
19. Deliliers, G.L., Annaloro, C., Marconi, M., Soligo, D., Morandi, P., Luchesini, C., Tagliaferri, E. Della Volpe, A. (2002) Harvesting of autologous blood stem cells after a mobilising regimen with low-dose cyclophosphamide. Leukemia & Lymphoma, 43, 1957 1960.
20. van Der Auwera, P., Platzer, E., Xu, Z.X., Schulz, R., Feugeas, O., Capdeville, R. Edwards, D.J. (2001) Pharmacodynamics and pharmacokinetics of single doses of subcutaneous pegylated human G-CSF mutant (Ro 25-8315) in healthy volunteers: comparison with single and multiple daily doses of filgrastim. American Journal of Hematology, 66, 245 251.
21. Devine, S.M., Vij, R., Rettig, M., Todt, L., McGlauchlen, K., Fisher, N., Devine, H., Link, D.C., Calandra, G., Bridger, G., Westervelt, P. Dipersio, J.F. (2008) Rapid mobilization of functional donor hematopoietic cells without G-CSF using AMD3100, an antagonist of the CXCR4/SDF-1 interaction. Blood, 112, 990 998.
22. Dingli, D., Nowakowski, G.S., Dispenzieri, A., Lacy, M.Q., Hayman, S., Litzow, M.R., Gastineau, D.A. Gertz, M.A. (2006) Cyclophosphamide mobilization does not improve outcome in patients receiving stem cell transplantation for multiple myeloma. Clinical Lymphoma & Myeloma, 6, 384 388.
23. DiPersio, J.F., Micallef, I.N., Stiff, P.J., Bolwell, B.J., Maziarz, R.T., Jacobsen, E., Nademanee, A., McCarty, J., Bridger, G. Calandra, G. (2009a) Phase III prospective randomized double-blind placebo-controlled trial of plerixafor plus granulocyte colony-stimulating factor compared with placebo plus granulocyte colony-stimulating factor for autologous stem-cell mobilization and transplantation for patients with non-Hodgkin's lymphoma. Journal of Clinical Oncology, 27, 4767 4773.
24. DiPersio, J.F., Stadtmauer, E.A., Nademanee, A., Micallef, I.N.M., Stiff, P.J., Kaufman, J.L., Maziarz, R.T., Hosing, C., Fruehauf, S., Horwitz, M., Cooper, D., Bridger, G. Calandra, G. (2009b) Plerixafor and G-CSF versus placebo and G-CSF to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myeloma. Blood, 113, 5720 5726.
25. Dugan, M.J., Maziarz, R.T., Bensinger, W.I., Nademanee, A., Liesveld, J., Badel, K., Dehner, C., Gibney, C., Bridger, G. Calandra, G. (2010) Safety and preliminary efficacy of plerixafor (Mozobil) in combination with chemotherapy and G-CSF: an open-label, multicenter, exploratory trial in patients with multiple myeloma and non-Hodgkin's lymphoma undergoing stem cell mobilization. Bone Marrow Transplantation, 45, 39 47.
26. Egan, K., Singh, V., Gidron, A. Mehta, J. (2007) Correlation between serum lactate dehydrogenase and stem cell mobilization. Bone Marrow Transplantation, 40, 931 934.
27. Elfenbein, G.J., Sackstein, R. Oblon, D.J. (2004) Do G-CSF mobilized, peripheral blood-derived stem cells from healthy, HLA-identical donors really engraft more rapidly than do G-CSF primed, bone marrow-derived stem cells? No Blood Cells Molecules & Diseases, 32, 106 111.
28. Fietz, T., Rieger, K., Dimeo, F., Blau, I.W., Thiel, E. Knauf, W.U. (2004) Stem cell mobilization in multiple myeloma patients: do we need an age-adjusted regimen for the elderly? Journal of Clinical Apheresis, 19, 202 207.
29. Fischer, J.C., Frick, M., Wassmuth, R., Platz, A., Punzel, M. Wernet, P. (2005) Superior mobilisation of haematopoietic progenitor cells with glycosylated G-CSF in male but not female unrelated stem cell donors. British Journal of Haematology, 130, 740 746.
30. Fitoussi, O., Perreau, V., Boiron, J.M., Bouzigon, E., Cony-Makhoul, P., Pigneux, A., Agape, P., Nicolini, F., Dazey, B., Reiffers, J., Salmi, R. Marit, G. (2001) A comparison of toxicity following two different doses of cyclophosphamide for mobilization of peripheral blood progenitor cells in 116 multiple myeloma patients. Bone Marrow Transplantation, 27, 837 842.
31. Ford, C.D., Green, W., Warenski, S. Petersen, F.B. (2004) Effect of prior chemotherapy on hematopoietic stem cell mobilization. Bone Marrow Transplantation, 33, 901 905.
32. Fowler, C.J., Dunn, A., Hayes-Lattin, B., Hansen, K., Hansen, L., Lanier, K., Nelson, V., Kovacsovics, T., Leis, J., Calandra, G. Maziarz, R.T. (2009) Rescue from failed growth factor and/or chemotherapy HSC mobilization with G-CSF and plerixafor (AMD3100): an institutional experience. Bone Marrow Transplantation, 43, 909 917.
33. Fox, C.P., McMillan, A.K., Bishton, M.J., Haynes, A.P. Russell, N.H. (2008) IVE (ifosfamide, epirubicin and etoposide) is a more effective stem cell mobilisation regimen than ICE (ifosphamide, carboplatin and etoposide) in the context of salvage therapy for lymphoma. British Journal of Haematology, 141, 244 248.
34. Fruehauf, S., Klaus, J., Huesing, J., Veldwijk, M.R., Buss, E.C., Topaly, J., Seeger, T., Zeller, L.W., Moehler, T., Ho, A.D., Goldschmidt, H. Zeller, L.W.J. (2007) Efficient mobilization of peripheral blood stem cells following CAD chemotherapy and a single dose of pegylated G-CSF in patients with multiple myeloma. Bone Marrow Transplantation, 39, 743 750.
35. Fruehauf, S., Veldwijk, M.R., Seeger, T., Schubert, M., Laufs, S., Topaly, J., Wuchter, P., Dillmann, F., Eckstein, V., Wenz, F., Goldschmidt, H., Ho, A.D. Calandra, G. (2009) A combination of granulocyte-colony-stimulating factor (G-CSF) and plerixafor mobilizes more primitive peripheral blood progenitor cells than G-CSF alone: results of a European phase II study. Cytotherapy, 11, 992 1001.
36. Fruehauf, S., Ehninger, G., Hubel, K., Topaly, J., Goldschmidt, H., Ho, A.D., Muller, S., Moos, M., Badel, K. Calandra, G. (2010) Mobilization of peripheral blood stem cells for autologous transplant in non-Hodgkin's lymphoma and multiple myeloma patients by plerixafor and G-CSF and detection of tumor cell mobilization by PCR in multiple myeloma patients. Bone Marrow Transplantation, 45, 269 275.
37. Gazitt, Y., Shaughnessy, P. Liu, Q. (2001) Differential mobilization of CD34+ cells and lymphoma cells in non-Hodgkin's lymphoma patients mobilized with different growth factors. Journal of Hematotherapy & Stem Cell Research, 10, 167 176.
38. Gazitt, Y., Akay, C., Thomas, 3rd., C., Gazitt, Y., Akay, C. Thomas, 3rd., C. (2006) No polarization of type 1 or type 2 precursor dendritic cells in peripheral blood stem cell collections of non-hodgkin's lymphoma patients mobilized with cyclophosphamide plus G-CSF, GM-CSF, or GM-CSF followed by G-CSF. Stem Cells & Development, 15, 269 277.
39. Gertz, M.A., Kumar, S.K., Lacy, M.Q., Dispenzieri, A., Hayman, S.R., Buadi, F.K., Dingli, D., Gastineau, D.A., Winters, J.L. Litzow, M.R. (2009) Comparison of high-dose CY and growth factor with growth factor alone for mobilization of stem cells for transplantation in patients with multiple myeloma. Bone Marrow Transplantation, 43, 619 625.
40. Gertz, M.A., Wolf, R.C., Micallef, I.N. Gastineau, D.A. (2010) Clinical impact and resource utilization after stem cell mobilization failure in patients with multiple myeloma and lymphoma. Bone Marrow Transplantation, doi:10.1038/bmt.
41. Ghobrial, I.M., Dispenzieri, A., Bundy, K.L., Gastineau, D.A., Rajkumar, S.V., Therneau, T.M., Lacy, M.Q., Witzig, T.E., Litzow, M.R., Christensen, B.R., Hayman, S., Pribula, C.G. Gertz, M.A. (2003) Effect of thalidomide on stem cell collection and engraftment in patients with multiple myeloma. Bone Marrow Transplantation, 32, 587 592.
42. Gobbi, P.G., Valentino, F., Lambelet, P., Perfetti, V., Bergamaschi, G., Girino, M. Corazza, G.R. (2009) Shortened and intensified MJMA: an effective salvage therapy for relapsed and refractory lymphomas and a strong mobilizer of PBSCs. Bone Marrow Transplantation, 44, 19 25.
43. Gojo, I., Guo, C., Sarkodee-Adoo, C., Meisenberg, B., Fassas, A., Rapoport, A.P., Cottler-Fox, M., Heyman, M., Takebe, N. Tricot, G. (2004) High-dose cyclophosphamide with or without etoposide for mobilization of peripheral blood progenitor cells in patients with multiple myeloma: efficacy and toxicity. Bone Marrow Transplantation, 34, 69 76.
44. Gordon, M.K., Sher, D., Karrison, T., Kebriaei, P., Chuang, K., Zhang, Y., McDonnell, D., Artz, A., Godley, L., Odenike, O., Rich, E., Michaelis, L., Thirman, M.J., Wickrema, A., van Besien, K., Larson, R.A. Stock, W. (2008) Successful autologous stem cell collection in patients with chronic myeloid leukemia in complete cytogenetic response, with quantitative measurement of BCR-ABL expression in blood, marrow, and apheresis products. Leukemia & Lymphoma, 49, 531 537.
45. Guardiola, P., Runde, V., Bacigalupo, A., Ruutu, T., Locatelli, F., Boogaerts, M.A., Pagliuca, A., Cornelissen, J.J., Schouten, H.C., Carreras, E., Finke, J., van Biezen, A., Brand, R., Niederwieser, D., Gluckman, E. de Witte, T.M. (2002) Retrospective comparison of bone marrow and granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells for allogeneic stem cell transplantation using HLA identical sibling donors in myelodysplastic syndromes. Blood, 99, 4370 4378.
46. Gupta, S., Zhou, P., Hassoun, H., Kewalramani, T., Reich, L., Costello, S., Drake, L., Klimek, V., Dhodapkar, M., Teruya-Feldstein, J., Hedvat, C., Kalakonda, N., Fleisher, M., Filippa, D., Qin, J., Nimer, S.D. Comenzo, R.L. (2005) Hematopoietic stem cell mobilization with intravenous melphalan and G-CSF in patients with chemoresponsive multiple myeloma: report of a phase II trial. Bone Marrow Transplantation, 35, 441 447.
47. Halle, P., Kanold, J., Rapatel, C., Boiret, N., Berger, M., Stephan, J.L., Albuisson, E., Tournilhac, O., Bonhomme, J. Demeocq, F. (2000) Granulocyte colony-stimulating factor alone at 20 micrograms/kg vs. 10 micrograms/kg for peripheral blood stem cell mobilization in children. Pediatric Transplantation, 4, 285 288.
48. Hart, C., Blank, C., Krause, S.W., Andreesen, R. Hennemann, B. (2007) Ifosfamide, epirubicin, and etoposide (IEV) mobilize peripheral blood stem cells more efficiently than cyclophosphamide/etoposide. Annals of Hematology, 86, 575 581.
49. Herbert, K.E., Prince, H.M., Ritchie, D.S. Seymour, J.F. (2009a) The role of ancestim (recombinant human stem-cell factor, rhSCF) in hematopoietic stem cell mobilization and hematopoietic reconstitution. Expert Opinion on Biological Therapy, 10, 113 125.
50. Herbert, K.E., Morgan, S., Prince, H.M., Westerman, D.A., Wolf, M.M., Carney, D.A., Yuen, K., di Iulio, J. Seymour, J.F. (2009b) Stem cell factor and high-dose twice daily filgrastim is an effective strategy for peripheral blood stem cell mobilization in patients with indolent lymphoproliferative disorders previously treated with fludarabine: results of a Phase II study with an historical comparator. Leukemia, 23, 305 312.
51. Hiwase, D.K., Bollard, G., Hiwase, S., Bailey, M., Muirhead, J. Schwarer, A.P. (2007) Intermediate-dose CY and G-CSF more efficiently mobilize adequate numbers of PBSC for tandem autologous PBSC transplantation compared with low-dose CY in patients with multiple myeloma. Cytotherapy, 9, 539 547.
52. Hiwase, D.K., Hiwase, S., Bailey, M., Bollard, G. Schwarer, A.P. (2008) The role of stem cell mobilization regimen on lymphocyte collection yield in patients with multiple myeloma. Cytotherapy, 10, 507 517.
53. Holig, K., Kramer, M., Kroschinsky, F., Bornhauser, M., Mengling, T., Schmidt, A.H., Rutt, C. Ehninger, G. (2009) Safety and efficacy of hematopoietic stem cell collection from mobilized peripheral blood in unrelated volunteers: 12 years of single-center experience in 3928 donors. Blood, 114, 3757 3763.
54. Horsfall, M.J., Hui, C.H., To, L.B., Begley, C.G., Basser, R.L. Simmons, P.J. (2000) Combination of stem cell factor and granulocyte colony-stimulating factor mobilizes the highest number of primitive haemopoietic progenitors as shown by pre-colony-forming unit (pre-CFU) assay. British Journal of Haematology, 109, 751 758.
55. Hosing, C., Saliba, R.M., Ahlawat, S., Korbling, M., Kebriaei, P., Alousi, A., De Lima, M., Okoroji, J.-G., McMannis, J., Qazilbash, M., Anderlini, P., Giralt, S., Champlin, R.E., Khouri, I. Popat, U. (2009) Poor hematopoietic stem cell mobilizers: a single institution study of incidence and risk factors in patients with recurrent or relapsed lymphoma. American Journal of Hematology, 84, 335 337.
56. Isidori, A., Tani, M., Bonifazi, F., Zinzani, P., Curti, A., Motta, M.R., Rizzi, S., Giudice, V., Farese, O., Rovito, M., Alinari, L., Conte, R., Baccarani, M. Lemoli, R.M. (2005) Phase II study of a single pegfilgrastim injection as an adjunct to chemotherapy to mobilize stem cells into the peripheral blood of pretreated lymphoma patients. Haematologica, 90, 225 231.
57. Jantunen, E., Putkonen, M., Nousiainen, T., Pelliniemi, T.T., Mahlamaki, E. Remes, K. (2003) Low-dose or intermediate-dose cyclophosphamide plus granulocyte colony-stimulating factor for progenitor cell mobilisation in patients with multiple myeloma. Bone Marrow Transplantation, 31, 347 351.
58. Jantunen, E., Itala, M., Siitonen, T., Kuittinen, T., Heiskanen, J., Koivunen, E., Juvonen, E., Silvennoinen, R., Nousiainen, T., Koistinen, P., Volin, L. Remes, K. (2008) Blood stem cell mobilization and collection in patients with chronic lymphocytic leukaemia: a nationwide analysis. Bone Marrow Transplantation, 41, 239 244.
59. Jeanne, M., Bouzgarrou, R., Lafarge, X., Fizet, D., Dazey, B., Vezon, G. Ivanovic, Z. (2003) Comparison of CD34+ cell collection on the CS-3000+ and Amicus blood cell separators. Transfusion, 43, 1423 1427.
60. Jillella, A.P., Ustun, C., Robach, E., Sertkaya, D., DiPiro, C., Kallab, A.M., Brick, W.G., Dainer, P.M., Kutlar, A., Townsend, A.R. Burgess, R.E. (2003) Infectious complications in patients receiving mobilization chemotherapy for autologous peripheral blood stem cell collection. Journal of Hematotherapy & Stem Cell Research, 12, 155 160.
61. Junghanss, C., Leithauser, M., Wilhelm, S., Kleine, H.D., Knopp, A., Decker, S., Alscher, A., Casper, J., Kohne, C.H. Freund, M. (2001) High-dose etoposide phosphate and G-CSF mobilizes peripheral blood stem cells in patients that previously failed to mobilize. Annals of Hematology, 80, 96 102.
62. Karanth, M., Chakrabarti, S., Lovell, R.A., Harvey, C., Holder, K., McConkey, C.C., McDonald, D., Fegan, C.D. Milligan, D.W. (2004) A randomised study comparing peripheral blood progenitor mobilisation using intermediate-dose cyclophosphamide plus lenograstim with lenograstim alone. Bone Marrow Transplantation, 34, 399 403.
63. Karlsson, L., Quinlan, D., Guo, D., Brown, C., Selinger, S., Klassen, J. Russell, J.A. (2004) Mobilized blood cells vs bone marrow harvest: experience compared in 171 donors with particular reference to pain and fatigue. Bone Marrow Transplantation, 33, 709 713.
64. Kasai, M., Kiyama, Y. Kawamura, A. (2002) Application of peripheral blood stem cells (PBSC) mobilized by recombinant human granulocyte colony stimulating factor for allogeneic PBSC transplantation and the comparison of allogeneic PBSC transplantation and bone marrow transplantation. Transfusion and apheresis science, 26, 121 127.
65. Keane, C., Gibbs, S., Seymour, J.F., Mills, A.K., Grimmett, K., Van Kuilenberg, R., Saal, R., Gill, D., Prince, H.M., Marlton, P. Mollee, P. (2006) The Hyper-CVAD chemotherapy regimen has an adverse long-term impact on the ability to mobilize peripheral blood stem cells, which can be readily circumvented by using the early cycles for mobilization. Hematological Oncology, 24, 159 163.
66. Kim, S., Kim, H.-J., Park, J.S., Lee, J., Chi, H.-S., Park, C.J., Huh, J. Suh, C. (2005) Prospective randomized comparative observation of single- vs split-dose lenograstim to mobilize peripheral blood progenitor cells following chemotherapy in patients with multiple myeloma or non-Hodgkin's lymphoma. Annals of Hematology, 84, 742 747.
67. Kim, M.K., Kim, S., Lee, S.S., Sym, S.J., Lee, D.H., Kim, S.W., Jang, S., Park, C.J., Chi, H.S., Huh, J. Suh, C. (2007) Rituximab-ESHAP as a mobilization regimen for relapsed or refractory B-cell lymphomas: a comparison with ESHAP. Transfusion, 47, 1447 1454.
68. Knudsen, L.M., Rasmussen, T., Nikolaisen, K. Johnsen, H.E. (2001) Mobilisation of tumour cells along with CD34+ cells to peripheral blood in multiple myeloma. European Journal of Haematology, 67, 289 295.
69. Kobbe, G., Bruns, I., Fenk, R., Czibere, A. Haas, R. (2009) Pegfilgrastim for PBSC mobilization and autologous haematopoietic SCT. Bone Marrow Transplantation, 43, 669 677.
70. Kopf, B., De Giorgi, U., Vertogen, B., Monti, G., Molinari, A., Turci, D., Dazzi, C., Leoni, M., Tienghi, A., Cariello, A., Argnani, M., Frassineti, L., Scarpi, E., Rosti, G. Marangolo, M. (2006) A randomized study comparing filgrastim versus lenograstim versus molgramostim plus chemotherapy for peripheral blood progenitor cell mobilization. Bone Marrow Transplantation, 38, 407 412.
71. Kroger, N., Renges, H., Sonnenberg, S., Kruger, W., Gutensohn, K., Dielschneider, T., Cortes-Dericks, L. Zander, A.R. (2002) Stem cell mobilisation with 16 microg/kg vs 10 microg/kg of G-CSF for allogeneic transplantation in healthy donors. Bone Marrow Transplantation, 29, 727 730.
72. Kroschinsky, F., Holig, K., Poppe-Thiede, K., Zimmer, K., Ordemann, R., Blechschmidt, M., Oelschlaegel, U., Bornhauser, M., Rall, G., Rutt, C. Ehninger, G. (2005) Single-dose pegfilgrastim for the mobilization of allogeneic CD34+ peripheral blood progenitor cells in healthy family and unrelated donors. Haematologica, 90, 1665 1671.
73. Kroschinsky, F., Holig, K., Platzbecker, U., Poppe-Thiede, K., Ordemann, R., Blechschmidt, M., Oelschlaegel, U., Schaich, M., Hanel, M., Bornhauser, M. Ehninger, G. (2006) Efficacy of single-dose pegfilgrastim after chemotherapy for the mobilization of autologous peripheral blood stem cells in patients with malignant lymphoma or multiple myeloma. Transfusion, 46, 1417 1423.
74. Kumar, S., Dispenzieri, A., Lacy, M.Q., Hayman, S.R., Buadi, F.K., Gastineau, D.A., Litzow, M.R., Fonseca, R., Roy, V., Rajkumar, S.V. Gertz, M.A. (2007) Impact of lenalidomide therapy on stem cell mobilization and engraftment post-peripheral blood stem cell transplantation in patients with newly diagnosed myeloma. Leukemia, 21, 2035 2042.
75. Kumar, S., Giralt, S., Stadtmauer, E.A., Harousseau, J.L., Palumbo, A., Bensinger, W., Comenzo, R.L., Lentzsch, S., Munshi, N., Niesvizky, R., San Miguel, J., Ludwig, H., Bergsagel, L., Blade, J., Lonial, S., Anderson, K.C., Tosi, P., Sonneveld, P., Sezer, O., Vesole, D., Cavo, M., Einsele, H., Richardson, P.G., Durie, B.G.M. Rajkumar, S.V. (2009) Mobilization in myeloma revisited: IMWG consensus perspectives on stem cell collection following initial therapy with thalidomide-, lenalidomide-, or bortezomib-containing regimens. Blood, 114, 1729 1735.
76. Laszlo, D., Galieni, P., Raspadori, D., Tozzi, M., Lauria, F. Martinelli, G. (2004) Fludarabine combination regimen severely affected peripheral blood stem cell mobilization. Acta Haematologica, 111, 228 229.
77. de Latour, R.P., Chaoui, D., Bourhis, J.-H., Belhocine, R., Park, S., Legrand, O., Brault, P., Rio, B., Assouad, S. Decaudin, D. (2007) Mobilization of peripheral blood progenitor cells after DHAP regimen with or without rituximab: a large multicenter comparative study in patients with malignant lymphoma. Leukemia & Lymphoma, 48, 897 904.
78. Lazzarino, M., Corso, A., Barbarano, L., Alessandrino, E.P., Cairoli, R., Pinotti, G., Ucci, G., Uziel, L., Rodeghiero, F., Fava, S., Ferrari, D., Fiumano, M., Frigerio, G., Isa, L., Luraschi, A., Montanara, S., Morandi, S., Perego, D., Santagostino, A., Savare, M., Vismara, A. Morra, E. (2001) DCEP (dexamethasone, cyclophosphamide, etoposide, and cisplatin) is an effective regimen for peripheral blood stem cell collection in multiple myeloma. Bone Marrow Transplantation, 28, 835 839.
79. Lefrere, F., Zohar, S., Bresson, J.-L., Chevret, S., Mogenet, A., Audat, F., Durand-Zaleski, I., Ghez, D., Dal Cortivo, L., Piesvaux, P., Cavazzana-Calvo, M. Varet, B. (2006a) A double-blind low dose-finding phase II study of granulocyte colony-stimulating factor combined with chemotherapy for stem cell mobilization in patients with non-Hodgkin's lymphoma. Haematologica, 91, 550 553.
80. Lefrere, F., Zohar, S., Ghez, D., Delarue, R., Audat, F., Suarez, F., Hermine, O., Damaj, G., Maillard, N., Ribeil, J.A., Azagury, M., Misbahi, R., Jondeau, K., Cavazzana-Calvo, M., Dal Cortivo, L. Varet, B. (2006b) The VAD chemotherapy regimen plus a G-CSF dose of 10 microg/kg is as effective and less toxic than high-dose cyclophosphamide plus a G-CSF dose of 5 microg/kg for progenitor cell mobilization: results from a monocentric study of 82 patients. Bone Marrow Transplantation, 37, 725 729.
81. Lemoli, R.M., de Vivo, A., Damiani, D., Isidori, A., Tani, M., Bonini, A., Cellini, C., Curti, A., Gugliotta, L., Visani, G., Fanin, R. Baccarani, M. (2003) Autologous transplantation of granulocyte colony-stimulating factor-primed bone marrow is effective in supporting myeloablative chemotherapy in patients with hematologic malignancies and poor peripheral blood stem cell mobilization. Blood, 102, 1595 1600.
82. Lerro, K.A., Medoff, E., Wu, Y., Seropian, S.E., Snyder, E., Krause, D. Cooper, D.L. (2003) A simplified approach to stem cell mobilization in multiple myeloma patients not previously treated with alkylating agents. Bone Marrow Transplantation, 32, 1113 1117.
83. Liles, W.C., Rodger, E., Broxmeyer, H.E., Dehner, C., Badel, K., Calandra, G., Christensen, J., Wood, B., Price, T.H. Dale, D.C. (2005) Augmented mobilization and collection of CD34+ hematopoietic cells from normal human volunteers stimulated with granulocyte-colony-stimulating factor by single-dose administration of AMD3100, a CXCR4 antagonist. Transfusion, 45, 295 300.
84. MacFarland, R., Hard, M.L., Scarborough, R., Badel, K. Calandra, G. (2010) A pharmacokinetic study of plerixafor in subjects with varying degrees of renal impairment. Biology of Blood & Marrow Transplantation, 16, 95 101.
85. Majado, M.J., Minguela, A., Gonzalez-Garcia, C., Salido, E., Blanquer, M., Funes, C., Insausti, C.L., Garcia-Hernandez, A.M., Moraleda, J.M. Morales, A. (2009) Large-volume-apheresis facilitates autologous transplantation of hematopoietic progenitors in poor mobilizer patients. Journal of Clinical Apheresis, 24, 12 17.
86. Mark, T., Stern, J., Furst, J.R., Jayabalan, D., Zafar, F., LaRow, A., Pearse, R.N., Harpel, J., Shore, T., Schuster, M.W., Leonard, J.P., Christos, P.J., Coleman, M. Niesvizky, R. (2008) Stem cell mobilization with cyclophosphamide overcomes the suppressive effect of lenalidomide therapy on stem cell collection in multiple myeloma. Biology of Blood & Marrow Transplantation, 14, 795 798.
87. Meldgaard Knudsen, L., Jensen, L., Gaarsdal, E., Nikolaisen, K. Johnsen, H.E. (2000) A comparative study of sequential priming and mobilisation of progenitor cells with rhG-CSF alone and high-dose cyclophosphamide plus rhG-CSF. Bone Marrow Transplantation, 26, 717 722.
88. Mele, A., Leopardi, G., Sparaventi, G., Nicolini, G., D'Adamo, F., Guiducci, B., Barulli, S., Malerba, L., Stramigioli, S., Talevi, N., Politi, P., Isidori, A., Malagola, M., Piccaluga, P. Visani, G. (2005) Mini-ICE effectively mobilises peripheral blood stem cells after fludarabine-based regimens in acute myeloid leukaemia. European Journal of Haematology, 74, 277 281.
89. Mendrone, A. Jr., Arrais, C.A., Saboya, R., Chamone, D.A.F. Dulley, F.L. (2008) Factors affecting hematopoietic progenitor cell mobilization: an analysis of 307 patients. Transfusion & Apheresis Science, 39, 187 192.
90. Merlin, E., Zohar, S., Jerome, C., Veyrat-Masson, R., Marceau, G., Paillard, C., Auvrignon, A., Le Moine, P., Gandemer, V., Sapin, V., Halle, P., Boiret-Dupre, N., Chevret, S., Demeocq, F., Dubray, C. Kanold, J. (2009) Hematopoietic progenitor cell mobilization and harvesting in children with malignancies: do the advantages of pegfilgrastim really translate into clinical benefit? Bone Marrow Transplantation, 43, 919 925.
91. Micallef, I.N., Stiff, P.J., DiPersio, J.F., Maziarz, R.T., McCarty, J.M., Bridger, G. Calandra, G. (2009) Successful stem cell remobilization using plerixafor (mozobil) plus granulocyte colony-stimulating factor in patients with non-hodgkin lymphoma: results from the plerixafor NHL phase 3 study rescue protocol. Biology of Blood & Marrow Transplantation, 15, 1578 1586.
92. Milone, G., Leotta, S., Indelicato, F., Mercurio, S., Moschetti, G., Di Raimondo, F., Tornello, A., Consoli, U., Guido, G. Giustolisi, R. (2003) G-CSF alone vs cyclophosphamide plus G-CSF in PBPC mobilization of patients with lymphoma: results depend on degree of previous pretreatment. Bone Marrow Transplantation, 31, 747 754.
93. Mollee, P., Pereira, D., Nagy, T., Song, K., Saragosa, R., Keating, A. Crump, M. (2002) Cyclophosphamide, etoposide and G-CSF to mobilize peripheral blood stem cells for autologous stem cell transplantation in patients with lymphoma. Bone Marrow Transplantation, 30, 273 278.
94. Moog, R. Moog, R. (2006) Mobilization and harvesting of peripheral blood stem cells. Current Stem Cell Research & Therapy, 1, 189 201.
95. Moog, R. Moog, R. (2008) Management strategies for poor peripheral blood stem cell mobilization. Transfusion & Apheresis Science, 38, 229 236.
96. Morris, C.L., Siegel, E., Barlogie, B., Cottler-Fox, M., Lin, P., Fassas, A., Zangari, M., Anaissie, E. Tricot, G. (2003) Mobilization of CD34+ cells in elderly patients (>/= 70 years) with multiple myeloma: influence of age, prior therapy, platelet count and mobilization regimen. British Journal of Haematology, 120, 413 423.
97. Nakasone, H., Kanda, Y., Ueda, T., Matsumoto, K., Shimizu, N., Minami, J., Sakai, R., Hagihara, M., Yokota, A., Oshima, K., Tsukada, Y., Tachibana, T., Nakaseko, C., Fujisawa, S., Yano, S., Fujita, H., Takahashi, S., Kanamori, H. Okamoto, S. (2009) Retrospective comparison of mobilization methods for autologous stem cell transplantation in multiple myeloma. American Journal of Hematology, 84, 809 814.
98. Narayanasami, U., Kanteti, R., Morelli, J., Klekar, A., Al-Olama, A., Keating, C., O'Connor, C., Berkman, E., Erban, J.K., Sprague, K.A., Miller, K.B. Schenkein, D.P. (2001) Randomized trial of filgrastim versus chemotherapy and filgrastim mobilization of hematopoietic progenitor cells for rescue in autologous transplantation. Blood, 98, 2059 2064.
99. Nickenig, C., Dreyling, M., Hoster, E., Ludwig, W.D., Dorken, B., Freund, M., Huber, C., Ganser, A., Trumper, L., Forstpointner, R., Unterhalt, M., Hiddemann, W. (2007) German Low-Grade Lymphoma Study. Initial chemotherapy with mitoxantrone, chlorambucil, prednisone impairs the collection of stem cells in patients with indolent lymphomas - results of a randomized comparison by the German Low-Grade Lymphoma Study Group. Annals of Oncology, 18, 136 142.
100. Nosari, A., Cairoli, R., Ciapanna, D., Gargantini, L., Intropido, L., Barate, C., Scarpati, B., Santoleri, L., Nador, G., Pezzetti, L. Morra, E. (2006) Efficacy of single dose pegfilgrastim in enhancing the mobilization of CD34+ peripheral blood stem cells in aggressive lymphoma patients treated with cisplatin-aracytin-containing regimens. Bone Marrow Transplantation, 38, 413 416.
101. Nowrousian, M.R., Waschke, S., Bojko, P., Welt, A., Schuett, P., Ebeling, P., Flasshove, M., Moritz, T., Schuette, J. Seeber, S. (2003) Impact of chemotherapy regimen and hematopoietic growth factor on mobilization and collection of peripheral blood stem cells in cancer patients. Annals of Oncology, 14 (Suppl. 1 i29 i36.
102. O'Connell, N., Gardiner, N., Duggan, C., Enright, H., Kennedy, M.J., McCann, S.R., Daly, P.A. Browne, P.V. (2001) Effective progenitor cell mobilization in lymphoproliferative disorders using ifosfamide, epirubicin and etoposide (IEV). European Journal of Haematology Supplementum, 64, 33 36.
103. Olivieri, A., Brunori, M., Capelli, D., Montanari, M., Massidda, D., Gini, G., Lucesole, M., Poloni, A., Offidani, M., Candela, M., Centurioni, R. Leoni, P. (2004) Salvage therapy with an outpatient DHAP schedule followed by PBSC transplantation in 79 lymphoma patients: an intention to mobilize and transplant analysis. European Journal of Haematology, 72, 10 17.
104. Paripati, H., Stewart, A.K., Cabou, S., Dueck, A., Zepeda, V.J., Pirooz, N., Ehlenbeck, C., Reeder, C., Slack, J., Leis, J.F., Boesiger, J., Torloni, A.S., Fonseca, R. Bergsagel, P.L. (2008) Compromised stem cell mobilization following induction therapy with lenalidomide in myeloma. Leukemia, 22, 1282 1284.
105. Park, I.H., Kim, Y., Kim, J.S., Cheong, J.W., Song, J.W. Min, Y.H. (2008) Transfusion-associated iron overload as a predictive factor for poor stem cell mobilization in patients with haematological malignancies. Transfusion Medicine, 18, 97 103.
106. Pastore, D., Specchia, G., Mestice, A., Liso, A., Pannunzio, A., Carluccio, P., Buquicchio, C., Greco, G., Ciuffreda, L., Pietrantuono, G. Liso, V. (2004) Good and poor CD34+ cells mobilization in acute leukemia: analysis of factors affecting the yield of progenitor cells. Bone Marrow Transplantation, 33, 1083 1087.
107. Pavone, V., Gaudio, F., Guarini, A., Perrone, T., Zonno, A., Curci, P. Liso, V. (2002) Mobilization of peripheral blood stem cells with high-dose cyclophosphamide or the DHAP regimen plus G-CSF in non-Hodgkin's lymphoma. Bone Marrow Transplantation, 29, 285 290.
108. Petrucci, M.T., Avvisati, G., La Verde, G., De Fabritiis, P., Ribersani, M., Palumbo, G., De Felice, L., Rusignuolo, A., Simone, F., Meloni, G. Mandelli, F. (2003) Intermediate-dose cyclophosphamide and granulocyte colony-stimulating factor is a valid alternative to high-dose cyclophosphamide for mobilizing peripheral blood CD34+ cells in patients with multiple myeloma. Acta Haematologica, 109, 184 188.
109. Pidala, J., Anasetti, C., Kharfan-Dabaja, M.A., Cutler, C., Sheldon, A. Djulbegovic, B. (2009) Decision analysis of peripheral blood versus bone marrow hematopoietic stem cells for allogeneic hematopoietic cell transplantation. Biology of Blood & Marrow Transplantation, 15, 1415 1421.
110. Pocali, B., De Simone, M., Annunziata, M., Palmieri, S., D'Amico, M.R., Copia, C., Viola, A., Mele, G., Schiavone, E.M. Ferrara, F. (2004) Ifosfamide, epirubicin and etoposide (IEV) regimen as salvage and mobilization therapy for refractory or early relapsing patients with aggressive non-Hodgkin's lymphoma. Leukemia & Lymphoma, 45, 1605 1609.
111. Popat, U., Saliba, R., Thandi, R., Hosing, C., Qazilbash, M., Anderlini, P., Shpall, E., McMannis, J., Korbling, M., Alousi, A., Andersson, B., Nieto, Y., Kebriaei, P., Khouri, I., de Lima, M., Weber, D., Thomas, S., Wang, M., Jones, R., Champlin, R. Giralt, S. (2009) Impairment of filgrastim-induced stem cell mobilization after prior lenalidomide in patients with multiple myeloma. Biology of Blood & Marrow Transplantation, 15, 718 723.
112. Porrata, L.F. Markovic, S.N. (2004) Timely reconstitution of immune competence affects clinical outcome following autologous stem cell transplantation. Clinical and experimental medicine, 4, 78 85.
113. Powles, R., Mehta, J., Kulkarni, S., Treleaven, J., Millar, B., Marsden, J., Shepherd, V., Rowland, A., Sirohi, B., Tait, D., Horton, C., Long, S. Singhal, S. (2000) Allogeneic blood and bone-marrow stem-cell transplantation in haematological malignant diseases: a randomised trial. Lancet, 355, 1231 1237.
114. Prosper, F., Sola, C., Hornedo, J., Arbona, C., Menendez, P., Orfao, A., Lluch, A., Cortes-Funes, H., Lopez, J.J. Garcia-Conde, J. (2003) Mobilization of peripheral blood progenitor cells with a combination of cyclophosphamide, r-metHuSCF and filgrastim in patients with breast cancer previously treated with chemotherapy. Leukemia, 17, 437 441.
115. Pusic, I., Jiang, S.Y., Landua, S., Uy, G.L., Rettig, M.P., Cashen, A.F., Westervelt, P., Vij, R., Abboud, C.N., Stockerl-Goldstein, K.E., Sempek, D.S., Smith, A.L. DiPersio, J.F. (2008) Impact of mobilization and remobilization strategies on achieving sufficient stem cell yields for autologous transplantation. Biology of Blood & Marrow Transplantation, 14, 1045 1056.
116. Putkonen, M., Rauhala, A., Pelliniemi, T.T. Remes, K. (2007) Sepsis, low platelet nadir at mobilization and previous IFN use predict stem cell mobilization failure in patients with multiple myeloma. Cytotherapy, 9, 548 554.
117. Raos, M., Nemet, D., Bojanic, I., Sertic, D., Batinic, D., Dusak, V., Dubravcic, K., Mazic, S., Serventi-Seiwerth, R., Mrsic, M., Golubic-Cepulic, B. Labar, B. (2010) Collection and composition of autologous peripheral blood stem cells graft in patients with acute myeloid leukemia: influence on hematopoietic recovery and outcome. Collegium antropologicum, 34, 105 115.
118. Ria, R., Gasparre, T., Mangialardi, G., Bruno, A., Iodice, G., Vacca, A. Dammacco, F. (2010) Comparison between filgrastim and lenograstim plus chemotherapy for mobilization of PBPCs. Bone Marrow Transplantation, 45, 277 281.
119. de la Rubia, J., de Arriba, F., Arbona, C., Pascual, M.J., Zamora, C., Insunza, A., Martinez, D., Paniagua, C., Diaz, M.A. Sanz, M.A. (2008) Follow-up of healthy donors receiving granulocyte colony-stimulating factor for peripheral blood progenitor cell mobilization and collection. Results of the Spanish Donor Registry. Haematologica, 93, 735 740.
120. Russell, N., Mesters, R., Schubert, J., Boogaerts, M., Johnsen, H.E., Canizo, C.D., Baker, N., Barker, P., Skacel, T. Schmitz, N. (2008) A phase 2 pilot study of pegfilgrastim and filgrastim for mobilizing peripheral blood progenitor cells in patients with non-Hodgkin's lymphoma receiving chemotherapy. Haematologica, 93, 405 412.
121. Schmitz, N., Beksac, M., Hasenclever, D., Bacigalupo, A., Ruutu, T., Nagler, A., Gluckman, E., Russell, N., Apperley, J.F., Gorin, N.C., Szer, J., Bradstock, K., Buzyn, A., Clark, P., Borkett, K. Gratwohl, A. (2002) Transplantation of mobilized peripheral blood cells to HLA-identical siblings with standard-risk leukemia. Blood, 100, 761 767.
122. Shimizu, N., Asai, T., Hashimoto, S., Narita, M., Kobayashi, M., Ito, M., Onoda, M., Yokota, A., Cho, R., Nakaseko, C., Nishimura, M. Saito, Y. (2002) Mobilization factors of peripheral blood stem cells in healthy donors. Therapeutic Apheresis, 6, 413 418.
123. Steidl, U., Fenk, R., Bruns, I., Neumann, F., Kondakci, M., Hoyer, B., Graf, T., Rohr, U.P., Bork, S., Kronenwett, R., Haas, R. Kobbe, G. (2005) Successful transplantation of peripheral blood stem cells mobilized by chemotherapy and a single dose of pegylated G-CSF in patients with multiple myeloma. Bone Marrow Transplantation, 35, 33 36.
124. Stewart, D.A., Smith, C., MacFarland, R. Calandra, G. (2009) Pharmacokinetics and pharmacodynamics of plerixafor in patients with non-Hodgkin lymphoma and multiple myeloma. Biology of Blood & Marrow Transplantation, 15, 39 46.
125. Stiff, P., Gingrich, R., Luger, S., Wyres, M.R., Brown, R.A., LeMaistre, C.F., Perry, J., Schenkein, D.P., List, A., Mason, J.R., Bensinger, W., Wheeler, C., Freter, C., Parker, W.R.L. Emmanouilides, C. (2000) A randomized phase 2 study of PBPC mobilization by stem cell factor and filgrastim in heavily pretreated patients with Hodgkin's disease or non-Hodgkin's lymphoma. Bone Marrow Transplantation, 26, 471 481.
126. Stiff, P., Micallef, I., McCarthy, P., Magalhaes-Silverman, M., Weisdorf, D., Territo, M., Badel, K. Calandra, G. (2009) Treatment with plerixafor in non-Hodgkin's lymphoma and multiple myeloma patients to increase the number of peripheral blood stem cells when given a mobilizing regimen of G-CSF: implications for the heavily pretreated patient. Biology of Blood & Marrow Transplantation, 15, 249 256.
127. Straka, C., Hebart, H., Adler-Reichel, S., Werding, N., Emmerich, B. Einsele, H. (2003) Blood stem cell collections after mobilization with combination chemotherapy containing ifosfamide followed by G-CSF in multiple myeloma. Oncology, 65 (Suppl. 2 94 98.
128. Tarella, C., Di Nicola, M., Caracciolo, D., Zallio, F., Cuttica, A., Omede, P., Bondesan, P., Magni, M., Matteucci, P., Gallamini, A., Pileri, A. Gianni, A.M. (2002) High-dose ara-C with autologous peripheral blood progenitor cell support induces a marked progenitor cell mobilization: an indication for patients at risk for low mobilization. Bone Marrow Transplantation, 30, 725 732.
129. To, L.B., Bashford, J., Durrant, S., MacMillan, J., Schwarer, A.P., Prince, H.M., Gibson, J., Lewis, I., Swart, B., Marty, J., Rawling, T., Ashman, L., Charles, S. Cohen, B. (2003) Successful mobilization of peripheral blood stem cells after addition of ancestim (stem cell factor) in patients who had failed a prior mobilization with filgrastim (granulocyte colony-stimulating factor) alone or with chemotherapy plus filgrastim. Bone Marrow Transplantation, 31, 371 378.
130. Toor, A.A., van Burik, J.A. Weisdorf, D.J. (2001) Infections during mobilizing chemotherapy and following autologous stem cell transplantation. Bone Marrow Transplantation, 28, 1129 1134.
131. Tournilhac, O., Cazin, B., Lepretre, S., Divine, M., Maloum, K., Delmer, A., Grosbois, B., Feugier, P., Maloisel, F., Villard, F., Villemagne, B., Bastit, D., Belhadj, K., Azar, N., Michallet, M., Manhes, G. Travade, P. (2004) Impact of frontline fludarabine and cyclophosphamide combined treatment on peripheral blood stem cell mobilization in B-cell chronic lymphocytic leukemia. Blood, 103, 363 365.
132. Tricot, G., Barlogie, B., Zangari, M., van Rhee, F., Hoering, A., Szymonifka, J. Cottler-Fox, M. (2008) Mobilization of peripheral blood stem cells in myeloma with either pegfilgrastim or filgrastim following chemotherapy. Haematologica, 93, 1739 1742.
133. Vela-Ojeda, J., Tripp-Villanueva, F., Montiel-Cervantes, L., Sanchez-Cortes, E., Ayala-Sanchez, M., Guevara-Moreno, M.E., Garcia-Leon, L.D., Rosas-Cabral, A., Esparza, M.A. Gonzalez-Llaven, J. (2000) Prospective randomized clinical trial comparing high-dose ifosfamide + GM-CSF vs high-dose cyclophosphamide + GM-CSF for blood progenitor cell mobilization. Bone Marrow Transplantation, 25, 1141 1146.
134. Vela-Ojeda, J., Garcia-Ruiz Esparza, M.A., Reyes-Maldonado, E., Jimenez-Zamudio, L., Garcia-Latorre, E., Moreno-Lafont, M., Estrada-Garcia, I., Montiel-Cervantes, L., Tripp-Villanueva, F., Ayala-Sanchez, M., Garcia-Leon, L.D., Borbolla-Escoboza, J.R. Mayani, H. (2006) Clinical relevance of NK, NKT, and dendritic cell dose in patients receiving G-CSF-mobilized peripheral blood allogeneic stem cell transplantation. Annals of Hematology, 85, 113 120.
135. Vellenga, E., van Agthoven, M., Croockewit, A.J., Verdonck, L.F., Wijermans, P.J., van Oers, M.H., Volkers, C.P., van Imhoff, G.W., Kingma, T., Uyl-de Groot, C.A. Fibbe, W.E. (2001) Autologous peripheral blood stem cell transplantation in patients with relapsed lymphoma results in accelerated haematopoietic reconstitution, improved quality of life and cost reduction compared with bone marrow transplantation: the Hovon 22 study. British Journal of Haematology, 114, 319 326.
136. Vicent, M.G., Madero, L., Chamorro, L., Madero, R. Diaz, M.A. (2001) Comparative cost analysis of autologous peripheral blood progenitor cell and bone marrow transplantation in pediatric patients with malignancies. Haematologica, 86, 1087 1094.
137. Vose, J.M., Sharp, G., Chan, W.C., Nichols, C., Loh, K., Inwards, D., Rifkin, R., Bierman, P.J., Lynch, J.C., Weisenburger, D.D., Kessinger, A. Armitage, J.O. (2002) Autologous transplantation for aggressive non-Hodgkin's lymphoma: results of a randomized trial evaluating graft source and minimal residual disease. Journal of Clinical Oncology, 20, 2344 2352.
138. Wang, S., Nademanee, A., Qian, D., Dagis, A., Park, H.S., Fridey, J., Smith, E., Snyder, D., Somlo, G., Stein, A., Rosenthal, J., Falk, P., Kogut, N., Palmer, J., Gaal, K., Kim, Y., Bhatia, R., Yuan, S., Kay, C., Weiss, L. Forman, S. (2007) Peripheral blood hematopoietic stem cell mobilization and collection efficacy is not an independent prognostic factor for autologous stem cell transplantation. Transfusion, 47, 2207 2216.
139. Watanabe, H., Watanabe, T., Suzuya, H., Wakata, Y., Kaneko, M., Onishi, T., Okamoto, Y., Abe, T., Kawano, Y., Kagami, S. Takaue, Y. (2006) Peripheral blood stem cell mobilization by granulocyte colony-stimulating factor alone and engraftment kinetics following autologous transplantation in children and adolescents with solid tumor. Bone Marrow Transplantation, 37, 661 668.
140. Watts, M.J., Ings, S.J., Flynn, M., Dodds, D., Goldstone, A.H. Linch, D.C. (2000) Remobilization of patients who fail to achieve minimal progenitor thresholds at the first attempt is clinically worthwhile. British Journal of Haematology, 111, 287 291.
141. Weaver, C.H., Schulman, K.A. Buckner, C.D. (2001) Mobilization of peripheral blood stem cells following myelosuppressive chemotherapy: a randomized comparison of filgrastim, sargramostim, or sequential sargramostim and filgrastim. Bone Marrow Transplantation, 27 (Suppl. 2 S23 S29.
142. White, J.M., Mufti, G.J., Salisbury, J.R. du Vivier, A.W. (2006) Cutaneous manifestations of granulocyte colony-stimulating factor. Clinical and Experimental Dermatology, 31, 206 207.
143. Willis, F., Woll, P., Theti, D., Jamali, H., Bacon, P., Baker, N. Pettengell, R. (2009) Pegfilgrastim for peripheral CD34+ mobilization in patients with solid tumours. Bone Marrow Transplantation, 43, 927 934.
144. Zhou, P., Zhang, Y., Martinez, C., Kalakonda, N., Nimer, S.D. Comenzo, R.L. (2003) Melphalan-mobilized blood stem cell components contain minimal clonotypic myeloma cell contamination. Blood, 102, 477 479.